<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

NEWSROOM Press Releases

    Year
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

    254 Results

    Lung Cancer Study Evaluating Changes in VeriStrat Status over the Course of Treatment with Gefitinib Published in Journal of Thoracic Oncology

    November 2, 2011

    Publication announced today: Changes in plasma mass-spectral (VeriStrat) profile in course of treatment of NSCLC patients with EGFR-TKIs.

    Biodesix Announces New VeriStrat® Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium

    November 22, 2011

    A retrospective analysis of serum samples from the phase III study, EGF30008, will be presented at the 34th Annual San Antonio Breast Cancer Symposium SABCS.

    Biodesix to Present at BioConference Live – Innovative Online Conference

    October 24, 2011

    BioConference Live has selected Biodesix to present at the 5th annual Life Sciences conference, taking place online on October 26–27.

    VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients

    October 18, 2011

    Data show that VeriStrat was able to stratify renal cell carcinoma (RCC) patients treated with a combination of two targeted therapies.

    Biodesix to Present at 2011 Biotech Showcase

    January 7, 2011

    Biodesix's Paul Beresford will present at the 2011 Biotech Showcase conference taking place January 10–12th at the Parc 55 Wyndham in San Francisco, CA

    VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy

    November 19, 2010

    The intention of the biomarker analysis was to evaluate the ability of VeriStrat, to predict patient outcomes with a combination regimen.

    Biodesix to Work with Concentra and Hooper Holmes to Expand Access to VeriStrat®

    October 13, 2011

    The initiation of two strategic partnerships that will provide cancer patients greater and more convenient options for completing VeriStrat testing.

    Biodesix Supports Unique Lung Cancer Research Initiative – CASTLE study enrolls initial subjects

    May 6, 2011

    Biodesix announces the enrollment of initial subjects into CASTLE, the inaugural study of the Addario Lung Cancer Medical Institute.

    Biodesix Receives Certification from NY State

    March 1, 2011

    Biodesix has received the clinical laboratory evaluation program certification from the New York State Department of Health’s Wadsworth Center.

    Biodesix Issued Four Additional U.S. Patents for Blood-based Oncology Tests

    April 12, 2011

    Biodesix announced that the U.S. Patent & Trademark Office has issued four patents for the protection of the company's products and technology.
    1 2 3 4